GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharnext SA (XPAR:ALPHA) » Definitions » Institutional Ownership

Pharnext (XPAR:ALPHA) Institutional Ownership : 25.58% (As of May. 21, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Pharnext Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pharnext's institutional ownership is 25.58%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pharnext's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pharnext's Float Percentage Of Total Shares Outstanding is 0.00%.

Pharnext Institutional Ownership Historical Data

The historical data trend for Pharnext's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharnext Institutional Ownership Chart

Pharnext Historical Data

The historical data trend for Pharnext can be seen below:

2022-02-28 2022-03-31 2022-04-30 2022-07-31 2022-08-31 2022-09-30 2022-10-31 2023-05-31 2023-09-30 2023-10-31
Institutional Ownership 0.47 0.40 0.40 14.00 35.00 45.00 2.03 48.56 28.56 25.58

Pharnext Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Pharnext (XPAR:ALPHA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharnext SA (XPAR:ALPHA) » Definitions » Institutional Ownership
Comparable Companies
XPAR:ALNEV OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN XBRU:UCB RPRX LEGN
Traded in Other Exchanges
P0X0:Germany
Address
11-13 Rue Rene Jacques, Issy-Les-Moulineaux, FRA, 92130
Website
http://www.pharnext.com
Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.

Pharnext (XPAR:ALPHA) Headlines

No Headlines